US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Atara Biotherapeutics

4.59

-0.1200-2.55%

Post-market: 4.590.00000.00%16:30 EDT

Volume:51.35K

Turnover:238.72K

Market Cap:37.54M

PE:1.79

High:4.99

Open:4.71

Low:4.59

Close:4.71

52wk High:19.15

52wk Low:3.92

Shares:8.18M

Float Shares:5.60M

Volume Ratio:0.71

T/O Rate:0.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.57

EPS(LYR):-11.4053

ROE:-2014.86%

ROA:47.81%

PB:-0.97

PE(LYR):-0.40

Loading ...

Overview Company News Filings

Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects

Atara Biotherapeutics Q4 EPS $(0.25) Beats $(0.44) Estimate, Sales $1.595M Miss $2.671M Estimate

Atara Biotherapeutics FY 2025 R&D expenses fall 75.3% to USD 37.45 million, net cash used in operating activities drops 25.9% to USD 50.9 million

Press Release: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress

Atara Schedules FDA Type A Meeting on EBVALLO Complete Response Letter

Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel

THOMSON REUTERS

BRIEF-Atara Biotherapeutics Provides Regulatory Update On Tabelecleucel

Atara Biotherapeutics reports Pierre Fabre request for FDA Type A meeting on tabelecleucel

Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel

THOMSON REUTERS

Atara Biotherapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Atara Biotherapeutics amends HealthCare Royalty purchase, sale agreement

Atara Biotherapeutics Extends $9 Million HCRx Milestone Payment Due Date to 2028

Atara Biotherapeutics Provides a Business Update

THOMSON REUTERS

Atara Biotherapeutics Inc - Hcrx Amends Due Date of $9 Mln Cash Payment

THOMSON REUTERS

Atara Biotherapeutics Inc - Payment Due Date Extended to January 1, 2028

THOMSON REUTERS

Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics

Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc

Atara's Outlook As Ebvallo Hits Second FDA CRL

Benzinga_recent_news

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ATRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATRA\",,,,,undefined,":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":4.59,"timestamp":1774641600000,"preClose":4.71,"halted":0,"volume":51349,"hourTrading":{"tag":"盘后","latestPrice":4.59,"preClose":4.59,"latestTime":"16:30 EDT","volume":14,"amount":64.41,"timestamp":1774643457328,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02547770700636945,"floatShares":5600599,"shares":8178114,"eps":2.57,"marketStatus":"Market Closed","change":-0.12,"latestTime":"03-27 16:00:00 EDT","open":4.71,"high":4.9899,"low":4.585,"amount":238717.15173969997,"amplitude":0.085966,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.57,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1413432000000,"exchange":"NASDAQ","adjPreClose":4.71,"preHourTrading":{"tag":"盘前","latestPrice":4.63,"preClose":4.71,"latestTime":"08:01 EDT","volume":42,"amount":194.2471944,"timestamp":1774612861630,"change":-0.08,"changeRate":-0.016985,"amplitude":0.038726},"postHourTrading":{"tag":"盘后","latestPrice":4.59,"preClose":4.59,"latestTime":"16:30 EDT","volume":14,"amount":64.41,"timestamp":1774643457328,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7067824350315861,"impliedVol":0.0156,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATRA\",,,,,undefined,":{"symbol":"ATRA","floatShares":5600599,"roa":"47.81%","roe":"-2014.86%","lyrEps":-11.405315,"volumeRatio":0.7067824350315861,"shares":8178114,"dividePrice":0,"high":4.9899,"amplitude":0.085966,"preClose":4.71,"low":4.585,"week52Low":3.92,"pbRate":"-0.97","psRate":"0.31","week52High":19.145,"institutionHeld":0,"latestPrice":4.59,"eps":2.57,"divideRate":0,"volume":51349,"delay":0,"ttmEps":2.57,"open":4.71,"prevYearClose":18.09,"prevWeekClose":4.91,"prevMonthClose":5.42,"prevQuarterClose":18.09,"fiveDayClose":4.91,"twentyDayClose":5.42,"sixtyDayClose":17.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-16","symbol":"ATRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.09,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-11-12","symbol":"ATRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-08-11","symbol":"ATRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":0.19},{"market":"US","date":"2025-05-15","symbol":"ATRA","fiscalQuarterEnding":"2025/03","expectedEps":-3.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":3.5},{"market":"US","date":"2025-03-07","symbol":"ATRA","fiscalQuarterEnding":"2024/12","expectedEps":-3.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741323600000,"reportTimeType":"post","actualEps":-1.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.25,"sell":0.25,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.25,"analysts":4,"updateTime":1771646400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATRA","date":"2026-03-27","current":1.785992,"percent":0.873366,"low":-5.656868,"twenty":-3.439279,"median":-0.90239,"eighty":-0.231819,"high":28.522215,"avg":-0.390475,"sd":4.585418,"marketCap":38518916},"quantilePoints":[{"date":"2021-04-01","current":-4.065937,"twenty":-12.85666,"median":-6.88488,"eighty":-3.157132,"marketCap":1246697458},{"date":"2021-04-09","current":-3.75506,"twenty":-12.742945,"median":-6.869396,"eighty":-3.1569,"marketCap":1151376525},{"date":"2021-04-16","current":-3.621438,"twenty":-12.643743,"median":-6.824351,"eighty":-3.1569,"marketCap":1110405247},{"date":"2021-04-23","current":-3.877259,"twenty":-12.554952,"median":-6.784507,"eighty":-3.1569,"marketCap":1188845061},{"date":"2021-04-30","current":-3.855322,"twenty":-12.506885,"median":-6.753144,"eighty":-3.1569,"marketCap":1182118922},{"date":"2021-05-07","current":-3.668703,"twenty":-12.332491,"median":-6.734261,"eighty":-3.1569,"marketCap":1142602855},{"date":"2021-05-14","current":-4.046641,"twenty":-12.201936,"median":-6.711738,"eighty":-3.1569,"marketCap":1260310287},{"date":"2021-05-21","current":-3.717295,"twenty":-12.04167,"median":-6.701173,"eighty":-3.1569,"marketCap":1157736668},{"date":"2021-05-28","current":-3.660604,"twenty":-11.945762,"median":-6.663994,"eighty":-3.1569,"marketCap":1140080553},{"date":"2021-06-04","current":-3.558021,"twenty":-11.860844,"median":-6.64417,"eighty":-3.1569,"marketCap":1108131393},{"date":"2021-06-11","current":-3.887367,"twenty":-11.734357,"median":-6.597131,"eighty":-3.1569,"marketCap":1210705012},{"date":"2021-06-18","current":-4.052041,"twenty":-11.65961,"median":-6.574843,"eighty":-3.1569,"marketCap":1261991822},{"date":"2021-06-25","current":-4.413782,"twenty":-11.620814,"median":-6.547695,"eighty":-3.1569,"marketCap":1374654649},{"date":"2021-07-02","current":-4.297701,"twenty":-11.573858,"median":-6.50798,"eighty":-3.1569,"marketCap":1338501653},{"date":"2021-07-09","current":-3.819878,"twenty":-11.523867,"median":-6.486512,"eighty":-3.1569,"marketCap":1189685828},{"date":"2021-07-16","current":-3.579617,"twenty":-11.435141,"median":-6.463405,"eighty":-3.1569,"marketCap":1114857532},{"date":"2021-07-23","current":-3.447339,"twenty":-11.392427,"median":-6.418944,"eighty":-3.1569,"marketCap":1073659931},{"date":"2021-07-30","current":-3.44194,"twenty":-11.358954,"median":-6.396421,"eighty":-3.1569,"marketCap":1071978396},{"date":"2021-08-06","current":-3.412245,"twenty":-11.202892,"median":-6.351967,"eighty":-3.1569,"marketCap":1062729955},{"date":"2021-08-13","current":-3.320604,"twenty":-11.111326,"median":-6.306331,"eighty":-3.1569,"marketCap":1055231509},{"date":"2021-08-20","current":-3.368613,"twenty":-10.950561,"median":-6.285104,"eighty":-3.1569,"marketCap":1070487869},{"date":"2021-08-27","current":-3.920713,"twenty":-10.869994,"median":-6.133353,"eighty":-3.1569,"marketCap":1245935999},{"date":"2021-09-03","current":-4.150088,"twenty":-10.808757,"median":-6.084516,"eighty":-3.1569,"marketCap":1318827493},{"date":"2021-09-10","current":-4.182094,"twenty":-10.771656,"median":-6.058582,"eighty":-3.1569,"marketCap":1328998399},{"date":"2021-09-17","current":-4.28878,"twenty":-10.72894,"median":-6.026645,"eighty":-3.1569,"marketCap":1362901420},{"date":"2021-09-24","current":-4.534158,"twenty":-10.669988,"median":-5.968492,"eighty":-3.1569,"marketCap":1440878367},{"date":"2021-10-01","current":-4.667516,"twenty":-10.577989,"median":-5.929441,"eighty":-3.1569,"marketCap":1483257142},{"date":"2021-10-08","current":-4.547494,"twenty":-10.545918,"median":-5.900924,"eighty":-3.1569,"marketCap":1445116244},{"date":"2021-10-15","current":-4.032734,"twenty":-10.489134,"median":-5.768077,"eighty":-3.1569,"marketCap":1281534171},{"date":"2021-10-22","current":-4.275444,"twenty":-10.423167,"median":-5.72307,"eighty":-3.1569,"marketCap":1358663542},{"date":"2021-10-29","current":-4.128751,"twenty":-10.423167,"median":-5.648136,"eighty":-3.1569,"marketCap":1312046889},{"date":"2021-11-05","current":-4.896522,"twenty":-10.423167,"median":-5.552729,"eighty":-3.1569,"marketCap":1606543903},{"date":"2021-11-12","current":-4.748306,"twenty":-10.393396,"median":-5.480725,"eighty":-3.1569,"marketCap":1557914341},{"date":"2021-11-19","current":-4.931555,"twenty":-10.312261,"median":-5.443441,"eighty":-3.1569,"marketCap":1618038163},{"date":"2021-11-26","current":-4.734831,"twenty":-10.248252,"median":-5.423247,"eighty":-3.1569,"marketCap":1553493472},{"date":"2021-12-03","current":-4.605479,"twenty":-10.167865,"median":-5.406157,"eighty":-3.1569,"marketCap":1511053126},{"date":"2021-12-10","current":-4.306352,"twenty":-10.114867,"median":-5.351009,"eighty":-3.1569,"marketCap":1412909828},{"date":"2021-12-17","current":-4.082681,"twenty":-10.070909,"median":-5.312947,"eighty":-3.1569,"marketCap":1339523397},{"date":"2021-12-23","current":-4.664766,"twenty":-10.000377,"median":-5.275664,"eighty":-3.1569,"marketCap":1530504951},{"date":"2021-12-31","current":-4.247066,"twenty":-10.000377,"median":-5.219738,"eighty":-3.1569,"marketCap":1393458003},{"date":"2022-01-07","current":-4.233591,"twenty":-9.989866,"median":-5.175187,"eighty":-3.157132,"marketCap":1389037134},{"date":"2022-01-14","current":-4.330606,"twenty":-9.961007,"median":-5.113595,"eighty":-3.157132,"marketCap":1420867393},{"date":"2022-01-21","current":-3.770079,"twenty":-9.961007,"median":-5.071783,"eighty":-3.157132,"marketCap":1236959230},{"date":"2022-01-28","current":-4.00453,"twenty":-9.961007,"median":-5.02065,"eighty":-3.157132,"marketCap":1313882355},{"date":"2022-02-04","current":-3.937159,"twenty":-9.961007,"median":-4.985734,"eighty":-3.157132,"marketCap":1291778009},{"date":"2022-02-11","current":-3.923685,"twenty":-9.933161,"median":-4.899216,"eighty":-3.157132,"marketCap":1287357140},{"date":"2022-02-18","current":-3.535628,"twenty":-9.927271,"median":-4.85142,"eighty":-3.157132,"marketCap":1160036104},{"date":"2022-02-25","current":-3.554492,"twenty":-9.927271,"median":-4.812982,"eighty":-3.157132,"marketCap":1166225321},{"date":"2022-03-04","current":-2.422273,"twenty":-9.860817,"median":-4.763948,"eighty":-3.145245,"marketCap":823914459},{"date":"2022-03-11","current":-2.468803,"twenty":-9.73795,"median":-4.724052,"eighty":-3.133131,"marketCap":839741064},{"date":"2022-03-18","current":-2.679554,"twenty":-9.667125,"median":-4.687497,"eighty":-3.109901,"marketCap":911426277},{"date":"2022-03-25","current":-2.57281,"twenty":-9.496312,"median":-4.664638,"eighty":-3.078143,"marketCap":875118182},{"date":"2022-04-01","current":-2.60018,"twenty":-9.41974,"median":-4.650041,"eighty":-3.058063,"marketCap":884427950},{"date":"2022-04-08","current":-2.39764,"twenty":-9.353968,"median":-4.632345,"eighty":-3.037531,"marketCap":815535668},{"date":"2022-04-14","current":-2.192363,"twenty":-9.235675,"median":-4.615216,"eighty":-3.013211,"marketCap":745712408},{"date":"2022-04-22","current":-1.987085,"twenty":-9.061426,"median":-4.585788,"eighty":-2.977344,"marketCap":675889149},{"date":"2022-04-29","current":-1.746512,"twenty":-8.896503,"median":-4.549538,"eighty":-2.960311,"marketCap":594060417},{"date":"2022-05-06","current":-1.847234,"twenty":-8.821896,"median":-4.512962,"eighty":-2.938752,"marketCap":646367623},{"date":"2022-05-13","current":-1.462839,"twenty":-8.821896,"median":-4.472701,"eighty":-2.903427,"marketCap":511863378},{"date":"2022-05-20","current":-1.377418,"twenty":-8.821896,"median":-4.404765,"eighty":-2.878693,"marketCap":481973546},{"date":"2022-05-27","current":-1.390765,"twenty":-8.821896,"median":-4.383385,"eighty":-2.835056,"marketCap":486643832},{"date":"2022-06-03","current":-1.372079,"twenty":-8.821896,"median":-4.349289,"eighty":-2.792124,"marketCap":480105431},{"date":"2022-06-10","current":-1.393434,"twenty":-8.821896,"median":-4.331031,"eighty":-2.759282,"marketCap":487577889},{"date":"2022-06-17","current":-1.566946,"twenty":-8.821896,"median":-4.3029,"eighty":-2.720678,"marketCap":548291611},{"date":"2022-06-24","current":-1.951342,"twenty":-8.825822,"median":-4.279404,"eighty":-2.710028,"marketCap":682795857},{"date":"2022-07-01","current":-2.215613,"twenty":-8.825822,"median":-4.240771,"eighty":-2.699115,"marketCap":775267525},{"date":"2022-07-08","current":-2.269002,"twenty":-8.825822,"median":-4.23277,"eighty":-2.692806,"marketCap":793948671},{"date":"2022-07-15","current":-1.027724,"twenty":-8.825822,"median":-4.220117,"eighty":-2.681196,"marketCap":359612045},{"date":"2022-07-22","current":-0.859551,"twenty":-8.825822,"median":-4.202286,"eighty":-2.667105,"marketCap":300766437},{"date":"2022-07-29","current":-0.808832,"twenty":-8.825822,"median":-4.195117,"eighty":-2.649754,"marketCap":283019349},{"date":"2022-08-05","current":-0.918278,"twenty":-8.825822,"median":-4.182094,"eighty":-2.635005,"marketCap":321315697},{"date":"2022-08-12","current":-2.225203,"twenty":-8.825822,"median":-4.160831,"eighty":-2.626804,"marketCap":551075948},{"date":"2022-08-19","current":-1.695574,"twenty":-8.825822,"median":-4.129681,"eighty":-2.60747,"marketCap":419912324},{"date":"2022-08-26","current":-1.535542,"twenty":-8.825822,"median":-4.101544,"eighty":-2.597817,"marketCap":380280149},{"date":"2022-09-02","current":-1.63461,"twenty":-8.825822,"median":-4.083409,"eighty":-2.592697,"marketCap":404814352},{"date":"2022-09-09","current":-1.836554,"twenty":-8.825822,"median":-4.054071,"eighty":-2.58627,"marketCap":454826382},{"date":"2022-09-16","current":-1.539353,"twenty":-8.825822,"median":-4.046641,"eighty":-2.572757,"marketCap":381223772},{"date":"2022-09-23","current":-1.261202,"twenty":-8.825822,"median":-4.034173,"eighty":-2.562107,"marketCap":312339279},{"date":"2022-09-30","current":-1.440285,"twenty":-8.825822,"median":-4.02629,"eighty":-2.553014,"marketCap":356689569},{"date":"2022-10-07","current":-1.455527,"twenty":-8.825822,"median":-4.002781,"eighty":-2.545795,"marketCap":360464062},{"date":"2022-10-14","current":-1.421234,"twenty":-8.825822,"median":-3.995393,"eighty":-2.540489,"marketCap":351971453},{"date":"2022-10-21","current":-1.611748,"twenty":-8.825822,"median":-3.974887,"eighty":-2.529966,"marketCap":399152613},{"date":"2022-10-28","current":-1.840365,"twenty":-8.825822,"median":-3.97015,"eighty":-2.523716,"marketCap":455770005},{"date":"2022-11-04","current":-1.809882,"twenty":-8.825822,"median":-3.938659,"eighty":-2.510716,"marketCap":448221020},{"date":"2022-11-11","current":-1.969927,"twenty":-8.825822,"median":-3.923874,"eighty":-2.503848,"marketCap":486727577},{"date":"2022-11-18","current":-1.639686,"twenty":-8.825822,"median":-3.917063,"eighty":-2.481817,"marketCap":405131920},{"date":"2022-11-25","current":-1.605126,"twenty":-8.825822,"median":-3.887367,"eighty":-2.461589,"marketCap":396592840},{"date":"2022-12-02","current":-1.827846,"twenty":-8.825822,"median":-3.877774,"eighty":-2.44425,"marketCap":451622469},{"date":"2022-12-09","current":-1.708806,"twenty":-8.825822,"median":-3.869594,"eighty":-2.434311,"marketCap":422210081},{"date":"2022-12-16","current":-1.351685,"twenty":-8.825822,"median":-3.856314,"eighty":-2.416355,"marketCap":333972918},{"date":"2022-12-23","current":-1.148164,"twenty":-8.825822,"median":-3.841377,"eighty":-2.384785,"marketCap":283687223},{"date":"2022-12-30","current":-1.259524,"twenty":-8.825822,"median":-3.819878,"eighty":-2.361486,"marketCap":311202037},{"date":"2023-01-06","current":-1.344005,"twenty":-8.825822,"median":-3.795582,"eighty":-2.33702,"marketCap":332075345},{"date":"2023-01-13","current":-1.493765,"twenty":-8.806189,"median":-3.776876,"eighty":-2.31985,"marketCap":369078026},{"date":"2023-01-20","current":-1.493765,"twenty":-8.670225,"median":-3.755089,"eighty":-2.306771,"marketCap":369078026},{"date":"2023-01-27","current":-2.023687,"twenty":-8.527881,"median":-3.725394,"eighty":-2.249037,"marketCap":500010590},{"date":"2023-02-03","current":-1.985287,"twenty":-8.456709,"median":-3.706074,"eighty":-2.193457,"marketCap":490522723},{"date":"2023-02-10","current":-1.789944,"twenty":-8.325655,"median":-3.688814,"eighty":-2.164565,"marketCap":408647788},{"date":"2023-02-17","current":-1.899189,"twenty":-8.139454,"median":-3.676802,"eighty":-2.116898,"marketCap":433588733},{"date":"2023-02-24","current":-1.705909,"twenty":-7.980818,"median":-3.660604,"eighty":-2.097825,"marketCap":389462446},{"date":"2023-03-03","current":-1.51683,"twenty":-7.848516,"median":-3.644407,"eighty":-2.064257,"marketCap":346295426},{"date":"2023-03-10","current":-1.189094,"twenty":-7.749269,"median":-3.624165,"eighty":-2.023579,"marketCap":271472592},{"date":"2023-03-17","current":-1.268927,"twenty":-7.584484,"median":-3.613991,"eighty":-2.004345,"marketCap":289698667},{"date":"2023-03-24","current":-1.205901,"twenty":-7.424315,"median":-3.598514,"eighty":-1.981319,"marketCap":275309660},{"date":"2023-03-31","current":-1.218506,"twenty":-7.332537,"median":-3.576981,"eighty":-1.950996,"marketCap":278187461},{"date":"2023-04-06","current":-1.168086,"twenty":-7.250833,"median":-3.565524,"eighty":-1.931366,"marketCap":266676256},{"date":"2023-04-14","current":-1.147007,"twenty":-7.095359,"median":-3.554492,"eighty":-1.895669,"marketCap":261864077},{"date":"2023-04-21","current":-1.20203,"twenty":-6.843537,"median":-3.53085,"eighty":-1.881801,"marketCap":274425823},{"date":"2023-04-28","current":-1.091985,"twenty":-6.706248,"median":-3.504954,"eighty":-1.856762,"marketCap":249302332},{"date":"2023-05-05","current":-1.163937,"twenty":-6.56802,"median":-3.480711,"eighty":-1.840365,"marketCap":265729230},{"date":"2023-05-12","current":-1.033857,"twenty":-6.361412,"median":-3.454026,"eighty":-1.821747,"marketCap":222246265},{"date":"2023-05-19","current":-0.929736,"twenty":-6.139895,"median":-3.442088,"eighty":-1.815179,"marketCap":199863381},{"date":"2023-05-26","current":-0.875045,"twenty":-6.055923,"median":-3.422526,"eighty":-1.807132,"marketCap":188106712},{"date":"2023-06-02","current":-0.683629,"twenty":-5.972415,"median":-3.417493,"eighty":-1.796408,"marketCap":146958369},{"date":"2023-06-09","current":-0.856815,"twenty":-5.879816,"median":-3.396668,"eighty":-1.789676,"marketCap":184187822},{"date":"2023-06-16","current":-0.975311,"twenty":-5.581624,"median":-3.381734,"eighty":-1.783976,"marketCap":209660606},{"date":"2023-06-23","current":-0.79301,"twenty":-5.465771,"median":-3.368613,"eighty":-1.772542,"marketCap":170471708},{"date":"2023-06-30","current":-0.742877,"twenty":-5.351009,"median":-3.348699,"eighty":-1.754886,"marketCap":159694760},{"date":"2023-07-07","current":-0.756549,"twenty":-5.280135,"median":-3.341338,"eighty":-1.745214,"marketCap":162633928},{"date":"2023-07-14","current":-0.906948,"twenty":-5.218317,"median":-3.322513,"eighty":-1.737487,"marketCap":194964769},{"date":"2023-07-21","current":-0.943408,"twenty":-5.142475,"median":-3.317713,"eighty":-1.721059,"marketCap":202802549},{"date":"2023-07-28","current":-0.815797,"twenty":-5.072964,"median":-3.285578,"eighty":-1.708806,"marketCap":175370320},{"date":"2023-08-04","current":-1.052789,"twenty":-4.996638,"median":-3.251137,"eighty":-1.69489,"marketCap":226315888},{"date":"2023-08-11","current":-0.723719,"twenty":-4.931555,"median":-3.200735,"eighty":-1.674761,"marketCap":220402691},{"date":"2023-08-18","current":-0.53117,"twenty":-4.869573,"median":-3.195657,"eighty":-1.654632,"marketCap":161763443},{"date":"2023-08-25","current":-0.497971,"twenty":-4.821066,"median":-3.183328,"eighty":-1.639686,"marketCap":151653228},{"date":"2023-09-01","current":-0.484692,"twenty":-4.774202,"median":-3.151745,"eighty":-1.611748,"marketCap":147609141},{"date":"2023-09-08","current":-0.511251,"twenty":-4.729496,"median":-3.140344,"eighty":-1.607938,"marketCap":155697314},{"date":"2023-09-15","current":-0.507931,"twenty":-4.699522,"median":-3.124149,"eighty":-1.601286,"marketCap":154686292},{"date":"2023-09-22","current":-0.590926,"twenty":-4.67395,"median":-3.108419,"eighty":-1.593316,"marketCap":179961830},{"date":"2023-09-28","current":-0.504611,"twenty":-4.662137,"median":-3.078971,"eighty":-1.580843,"marketCap":153675271},{"date":"2023-10-06","current":-0.464773,"twenty":-4.639244,"median":-3.059334,"eighty":-1.569081,"marketCap":141543012},{"date":"2023-10-13","current":-0.501291,"twenty":-4.617653,"median":-3.042406,"eighty":-1.547838,"marketCap":152664249},{"date":"2023-10-20","current":-0.458134,"twenty":-4.601168,"median":-3.012055,"eighty":-1.527719,"marketCap":139520969},{"date":"2023-10-27","current":-0.444855,"twenty":-4.570108,"median":-2.997338,"eighty":-1.520301,"marketCap":135476883},{"date":"2023-11-03","current":-0.417875,"twenty":-4.529813,"median":-2.962163,"eighty":-1.513558,"marketCap":121287477},{"date":"2023-11-10","current":-0.084277,"twenty":-4.495251,"median":-2.940426,"eighty":-1.493765,"marketCap":24461340},{"date":"2023-11-17","current":-0.16873,"twenty":-4.413478,"median":-2.921482,"eighty":-1.481669,"marketCap":48973641},{"date":"2023-11-24","current":-0.228848,"twenty":-4.393647,"median":-2.888721,"eighty":-1.456989,"marketCap":66422730},{"date":"2023-12-01","current":-0.231763,"twenty":-4.379093,"median":-2.842011,"eighty":-1.44254,"marketCap":67268685},{"date":"2023-12-08","current":-0.244018,"twenty":-4.33972,"median":-2.814054,"eighty":-1.411487,"marketCap":70825771},{"date":"2023-12-15","current":-0.240331,"twenty":-4.325987,"median":-2.769832,"eighty":-1.390757,"marketCap":69755587},{"date":"2023-12-22","current":-0.15658,"twenty":-4.294133,"median":-2.726844,"eighty":-1.383131,"marketCap":45447131},{"date":"2023-12-29","current":-0.192609,"twenty":-4.272034,"median":-2.715933,"eighty":-1.377418,"marketCap":55904354},{"date":"2024-01-05","current":-0.158406,"twenty":-4.240771,"median":-2.709477,"eighty":-1.372079,"marketCap":45977126},{"date":"2024-01-12","current":-0.211642,"twenty":-4.228202,"median":-2.697965,"eighty":-1.353393,"marketCap":61428540},{"date":"2024-01-19","current":-0.256344,"twenty":-4.217437,"median":-2.687765,"eighty":-1.344005,"marketCap":74403242},{"date":"2024-01-26","current":-0.211782,"twenty":-4.202286,"median":-2.67941,"eighty":-1.329368,"marketCap":61469308},{"date":"2024-02-02","current":-0.291459,"twenty":-4.195117,"median":-2.660859,"eighty":-1.300005,"marketCap":84595467},{"date":"2024-02-09","current":-0.29002,"twenty":-4.182094,"median":-2.646508,"eighty":-1.291685,"marketCap":84177586},{"date":"2024-02-16","current":-0.270917,"twenty":-4.160831,"median":-2.632972,"eighty":-1.282447,"marketCap":78633015},{"date":"2024-02-23","current":-0.276395,"twenty":-4.139272,"median":-2.625813,"eighty":-1.268823,"marketCap":80223002},{"date":"2024-03-01","current":-0.273199,"twenty":-4.113941,"median":-2.609292,"eighty":-1.259524,"marketCap":79295510},{"date":"2024-03-08","current":-0.24451,"twenty":-4.096871,"median":-2.599298,"eighty":-1.248726,"marketCap":70968462},{"date":"2024-03-15","current":-0.221228,"twenty":-4.063564,"median":-2.592911,"eighty":-1.231854,"marketCap":64211017},{"date":"2024-03-22","current":-0.234923,"twenty":-4.047811,"median":-2.586167,"eighty":-1.205901,"marketCap":68185985},{"date":"2024-03-28","current":-0.258381,"twenty":-4.035832,"median":-2.57281,"eighty":-1.201699,"marketCap":71345575},{"date":"2024-04-05","current":-0.33669,"twenty":-4.026348,"median":-2.562067,"eighty":-1.172402,"marketCap":92968904},{"date":"2024-04-12","current":-0.308118,"twenty":-4.00453,"median":-2.553014,"eighty":-1.148164,"marketCap":85079259},{"date":"2024-04-19","current":-0.298997,"twenty":-3.995393,"median":-2.545736,"eighty":-1.142775,"marketCap":82560779},{"date":"2024-04-26","current":-0.302498,"twenty":-3.979799,"median":-2.542703,"eighty":-1.092047,"marketCap":83527589},{"date":"2024-05-03","current":-0.28359,"twenty":-3.973022,"median":-2.529966,"eighty":-1.040368,"marketCap":78306614},{"date":"2024-05-10","current":-0.281944,"twenty":-3.954644,"median":-2.525166,"eighty":-1.003567,"marketCap":65723128},{"date":"2024-05-17","current":-0.311802,"twenty":-3.930191,"median":-2.512284,"eighty":-0.982603,"marketCap":72683180},{"date":"2024-05-24","current":-0.335771,"twenty":-3.920713,"median":-2.504396,"eighty":-0.96729,"marketCap":78270489},{"date":"2024-05-31","current":-0.293515,"twenty":-3.909748,"median":-2.495593,"eighty":-0.957081,"marketCap":68420449},{"date":"2024-06-07","current":-0.29398,"twenty":-3.87899,"median":-2.463329,"eighty":-0.947966,"marketCap":68528824},{"date":"2024-06-14","current":-0.272491,"twenty":-3.87387,"median":-2.445213,"eighty":-0.934293,"marketCap":63519512},{"date":"2024-06-21","current":-0.183899,"twenty":-3.859231,"median":-2.440081,"eighty":-0.91424,"marketCap":42868140},{"date":"2024-06-28","current":-0.170675,"twenty":-3.857155,"median":-2.426207,"eighty":-0.902288,"marketCap":39785487},{"date":"2024-07-05","current":-0.15931,"twenty":-3.857155,"median":-2.411385,"eighty":-0.87778,"marketCap":37136332},{"date":"2024-07-12","current":-0.209727,"twenty":-3.857155,"median":-2.378874,"eighty":-0.870488,"marketCap":48888946},{"date":"2024-07-15","current":-0.21634,"twenty":-3.857155,"median":-2.374538,"eighty":-0.866842,"marketCap":50430273},{"date":"2024-08-02","current":-0.214893,"twenty":-3.869127,"median":-2.330398,"eighty":-0.847806,"marketCap":50093108},{"date":"2024-08-09","current":-0.158484,"twenty":-3.869127,"median":-2.311712,"eighty":-0.826735,"marketCap":36943667},{"date":"2024-08-16","current":-0.185419,"twenty":-3.869127,"median":-2.274615,"eighty":-0.792932,"marketCap":33569784},{"date":"2024-08-23","current":-0.193292,"twenty":-3.869127,"median":-2.225203,"eighty":-0.759089,"marketCap":34995148},{"date":"2024-08-30","current":-0.191663,"twenty":-3.869127,"median":-2.188256,"eighty":-0.735098,"marketCap":34700245},{"date":"2024-09-06","current":-0.271478,"twenty":-3.869127,"median":-2.145911,"eighty":-0.718621,"marketCap":49150490},{"date":"2024-09-13","current":-0.219354,"twenty":-3.869127,"median":-2.115116,"eighty":-0.671779,"marketCap":39713595},{"date":"2024-09-20","current":-0.248522,"twenty":-3.869127,"median":-2.079473,"eighty":-0.585614,"marketCap":44994415},{"date":"2024-09-27","current":-0.24006,"twenty":-3.869127,"median":-2.034689,"eighty":-0.537145,"marketCap":43462449},{"date":"2024-10-04","current":-0.225644,"twenty":-3.869127,"median":-2.007391,"eighty":-0.519882,"marketCap":40852432},{"date":"2024-10-11","current":-0.243821,"twenty":-3.869127,"median":-1.989127,"eighty":-0.509923,"marketCap":44143323},{"date":"2024-10-18","current":-0.293964,"twenty":-3.869127,"median":-1.969927,"eighty":-0.501291,"marketCap":53221641},{"date":"2024-10-25","current":-0.265132,"twenty":-3.869127,"median":-1.940468,"eighty":-0.497971,"marketCap":48001608},{"date":"2024-10-31","current":-0.300232,"twenty":-3.869127,"median":-1.903391,"eighty":-0.491332,"marketCap":54356431},{"date":"2024-11-08","current":-0.316529,"twenty":-3.869283,"median":-1.882185,"eighty":-0.469421,"marketCap":57306884},{"date":"2024-11-15","current":-0.54413,"twenty":-3.869283,"median":-1.868211,"eighty":-0.465679,"marketCap":72456328},{"date":"2024-11-22","current":-0.458929,"twenty":-3.869283,"median":-1.842868,"eighty":-0.460768,"marketCap":61110947},{"date":"2024-11-29","current":-0.526622,"twenty":-3.869283,"median":-1.8322,"eighty":-0.460768,"marketCap":70124956},{"date":"2024-12-06","current":-0.541112,"twenty":-3.869283,"median":-1.817505,"eighty":-0.460768,"marketCap":72054472},{"date":"2024-12-13","current":-0.473635,"twenty":-3.869283,"median":-1.809882,"eighty":-0.460768,"marketCap":63069262},{"date":"2024-12-20","current":-0.429516,"twenty":-3.869283,"median":-1.800357,"eighty":-0.453636,"marketCap":57194317},{"date":"2024-12-27","current":-0.561442,"twenty":-3.869283,"median":-1.790831,"eighty":-0.453636,"marketCap":74761555},{"date":"2025-01-03","current":-0.612482,"twenty":-3.869283,"median":-1.788234,"eighty":-0.453636,"marketCap":81558060},{"date":"2025-01-10","current":-0.714994,"twenty":-3.869438,"median":-1.7794,"eighty":-0.453313,"marketCap":95208667},{"date":"2025-01-17","current":-0.338682,"twenty":-3.869438,"median":-1.766681,"eighty":-0.450075,"marketCap":45098842},{"date":"2025-01-24","current":-0.299753,"twenty":-3.869438,"median":-1.748466,"eighty":-0.442936,"marketCap":39915067},{"date":"2025-01-31","current":-0.367229,"twenty":-3.869438,"median":-1.739526,"eighty":-0.42444,"marketCap":48900277},{"date":"2025-02-07","current":-0.454603,"twenty":-3.869438,"median":-1.728187,"eighty":-0.402612,"marketCap":60534972},{"date":"2025-02-14","current":-0.377178,"twenty":-3.869438,"median":-1.713007,"eighty":-0.385236,"marketCap":50225020},{"date":"2025-02-21","current":-0.325273,"twenty":-3.869438,"median":-1.701707,"eighty":-0.369404,"marketCap":43313320},{"date":"2025-02-28","current":-0.298023,"twenty":-3.869438,"median":-1.680233,"eighty":-0.364729,"marketCap":39684677},{"date":"2025-03-07","current":-0.29413,"twenty":-3.869594,"median":-1.658178,"eighty":-0.355551,"marketCap":39166300},{"date":"2025-03-14","current":-0.462652,"twenty":-3.869594,"median":-1.648593,"eighty":-0.355551,"marketCap":39511885},{"date":"2025-03-21","current":-0.462385,"twenty":-3.869594,"median":-1.648593,"eighty":-0.355551,"marketCap":39489046},{"date":"2025-03-28","current":-0.471989,"twenty":-3.869594,"median":-1.635562,"eighty":-0.355551,"marketCap":40309293},{"date":"2025-04-04","current":-0.40613,"twenty":-3.869594,"median":-1.611748,"eighty":-0.355551,"marketCap":34684741},{"date":"2025-04-11","current":-0.363596,"twenty":-3.869438,"median":-1.610347,"eighty":-0.356068,"marketCap":31052217},{"date":"2025-04-17","current":-0.400642,"twenty":-3.869438,"median":-1.6046,"eighty":-0.356068,"marketCap":34216028},{"date":"2025-04-25","current":-0.521383,"twenty":-3.869594,"median":-1.589311,"eighty":-0.355551,"marketCap":44527708},{"date":"2025-05-02","current":-0.518639,"twenty":-3.869594,"median":-1.56828,"eighty":-0.355551,"marketCap":44293352},{"date":"2025-05-09","current":-0.509035,"twenty":-3.869594,"median":-1.535542,"eighty":-0.355551,"marketCap":43473104},{"date":"2025-05-16","current":-2.850604,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":44586297},{"date":"2025-05-23","current":-2.663311,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":41656842},{"date":"2025-05-30","current":-2.972882,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":46498849},{"date":"2025-06-06","current":-3.209188,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":50194912},{"date":"2025-06-13","current":-3.319718,"twenty":-3.869594,"median":-1.520301,"eighty":-0.355551,"marketCap":51923715},{"date":"2025-06-20","current":-3.056733,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":47810355},{"date":"2025-06-27","current":-3.030053,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":47393058},{"date":"2025-07-03","current":-3.226339,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":50463174},{"date":"2025-07-11","current":-3.613195,"twenty":-3.870139,"median":-1.520301,"eighty":-0.355331,"marketCap":56513986},{"date":"2025-07-18","current":-4.218755,"twenty":-3.877794,"median":-1.520301,"eighty":-0.355331,"marketCap":65985547},{"date":"2025-07-25","current":-5.313633,"twenty":-3.899391,"median":-1.520301,"eighty":-0.355331,"marketCap":83110530},{"date":"2025-08-01","current":-5.005155,"twenty":-3.921063,"median":-1.520301,"eighty":-0.355331,"marketCap":78285634},{"date":"2025-08-08","current":-4.761849,"twenty":-3.930868,"median":-1.520301,"eighty":-0.355331,"marketCap":74480082},{"date":"2025-08-15","current":13.743703,"twenty":-3.937459,"median":-1.513558,"eighty":-0.349195,"marketCap":79644760},{"date":"2025-08-22","current":13.925963,"twenty":-3.937459,"median":-1.493765,"eighty":-0.33554,"marketCap":80700957},{"date":"2025-08-29","current":14.980409,"twenty":-3.937459,"median":-1.482245,"eighty":-0.323584,"marketCap":86811473},{"date":"2025-09-05","current":15.513693,"twenty":-3.937759,"median":-1.459183,"eighty":-0.318266,"marketCap":89901849},{"date":"2025-09-12","current":14.738008,"twenty":-3.937459,"median":-1.447906,"eighty":-0.314998,"marketCap":85406757},{"date":"2025-09-19","current":14.628927,"twenty":-3.937459,"median":-1.414789,"eighty":-0.31238,"marketCap":84774634},{"date":"2025-09-26","current":16.76206,"twenty":-3.937459,"median":-1.390765,"eighty":-0.309994,"marketCap":97136139},{"date":"2025-10-03","current":17.549865,"twenty":-3.937459,"median":-1.383131,"eighty":-0.307239,"marketCap":101701467},{"date":"2025-10-10","current":19.489076,"twenty":-3.937459,"median":-1.377418,"eighty":-0.301349,"marketCap":112939198},{"date":"2025-10-17","current":18.47705,"twenty":-3.937459,"median":-1.367045,"eighty":-0.299621,"marketCap":107074507},{"date":"2025-10-24","current":17.113542,"twenty":-3.937459,"median":-1.347845,"eighty":-0.298408,"marketCap":99172977},{"date":"2025-10-31","current":17.022642,"twenty":-3.937459,"median":-1.334707,"eighty":-0.294531,"marketCap":98646209},{"date":"2025-11-07","current":14.325926,"twenty":-3.937459,"median":-1.310945,"eighty":-0.293494,"marketCap":83018739},{"date":"2025-11-14","current":16.228777,"twenty":-3.924842,"median":-1.291996,"eighty":-0.290418,"marketCap":94045762},{"date":"2025-11-21","current":4.073301,"twenty":-3.917793,"median":-1.286405,"eighty":-0.287842,"marketCap":95319306},{"date":"2025-11-28","current":4.65256,"twenty":-3.879809,"median":-1.268927,"eighty":-0.283616,"marketCap":108874548},{"date":"2025-12-05","current":4.375255,"twenty":-3.872631,"median":-1.259524,"eighty":-0.279619,"marketCap":102385337},{"date":"2025-12-12","current":5.490637,"twenty":-3.85552,"median":-1.247919,"eighty":-0.274466,"marketCap":128486387},{"date":"2025-12-19","current":5.308848,"twenty":-3.835294,"median":-1.218506,"eighty":-0.271366,"marketCap":124232349},{"date":"2025-12-26","current":5.41977,"twenty":-3.796749,"median":-1.205901,"eighty":-0.270453,"marketCap":126828033},{"date":"2026-01-02","current":5.573828,"twenty":-3.777378,"median":-1.201699,"eighty":-0.267335,"marketCap":130433151},{"date":"2026-01-09","current":5.373552,"twenty":-3.755066,"median":-1.172402,"eighty":-0.263816,"marketCap":125746498},{"date":"2026-01-16","current":1.423498,"twenty":-3.720766,"median":-1.148164,"eighty":-0.258521,"marketCap":33311285},{"date":"2026-01-23","current":1.540583,"twenty":-3.694267,"median":-1.142775,"eighty":-0.255292,"marketCap":36051175},{"date":"2026-01-30","current":1.697722,"twenty":-3.678422,"median":-1.091985,"eighty":-0.252428,"marketCap":39728394},{"date":"2026-02-06","current":1.389606,"twenty":-3.646567,"median":-1.038402,"eighty":-0.248146,"marketCap":32518159},{"date":"2026-02-13","current":1.371119,"twenty":-3.617614,"median":-1.002656,"eighty":-0.245698,"marketCap":32085545},{"date":"2026-02-20","current":1.306414,"twenty":-3.583396,"median":-0.993541,"eighty":-0.244711,"marketCap":30571396},{"date":"2026-02-27","current":1.620693,"twenty":-3.561092,"median":-0.971667,"eighty":-0.243426,"marketCap":37925836},{"date":"2026-03-06","current":1.540583,"twenty":-3.53365,"median":-0.957081,"eighty":-0.240277,"marketCap":36051175},{"date":"2026-03-13","current":2.126004,"twenty":-3.51791,"median":-0.947966,"eighty":-0.23779,"marketCap":49750621},{"date":"2026-03-20","current":1.280958,"twenty":-3.481354,"median":-0.929736,"eighty":-0.234071,"marketCap":41871943},{"date":"2026-03-27","current":1.178381,"twenty":-3.439279,"median":-0.90239,"eighty":-0.231819,"marketCap":38518916}],"updateTime":1774760096431},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622487292","title":"Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2622487292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622487292?lang=en_us&edition=fundamental","pubTime":"2026-03-28 02:11","pubTimestamp":1774635081,"startTime":"0","endTime":"0","summary":"Atara (ATRA) told investors it was nearing a breakthrough. A first-of-its-kind cancer therapy. Strong data. A clear path to FDA approval. The compl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/atara-biotherapeutics-faces-federal-securities-lawsuit-over-alleged-misstatements-about-drug-approval-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/atara-biotherapeutics-faces-federal-securities-lawsuit-over-alleged-misstatements-about-drug-approval-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US12M.BOND","BK4588","ATRA","US6M.BOND","TLT","US7Y.BOND","US30Y.BOND","BK4585","US2Y.BOND","TLTW","TMF","LABU","US3Y.BOND","US10Y.BOND","BK4139","US5Y.BOND"],"gpt_icon":0},{"id":"2620749137","title":"Atara Biotherapeutics Q4 EPS $(0.25) Beats $(0.44) Estimate, Sales $1.595M Miss $2.671M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2620749137","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620749137?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:27","pubTimestamp":1773692857,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Q4 EPS $(0.25) Beats $(0.44) Estimate, Sales $1.595M Miss $2.671M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51283615/atara-biotherapeutics-q4-eps-0-25-beats-0-44-estimate-sales-1-595m-miss-2-671m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Atara Biotherapeutics Q4 EPS $(0.25) Beats $(0.44) Estimate, Sales $1.595M Miss $2.671M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA"],"gpt_icon":0},{"id":"2620995094","title":"Atara Biotherapeutics FY 2025 R&D expenses fall 75.3% to USD 37.45 million, net cash used in operating activities drops 25.9% to USD 50.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620995094","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620995094?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:06","pubTimestamp":1773691595,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics FY 2025 R&D expenses fall 75.3% to USD 37.45 million, net cash used in operating activities drops 25.9% to USD 50.9 million. Atara published a press release reporting Q4 and full-year 2025 financial results and business updates. Cash, cash equivalents and short-term investments totaled USD 8.5 million at Dec. 31, 2025, down 80% year over year. FY 2025 commercialization revenue was USD 120.77 million, down 6% year over year. Q4 2025 net loss was USD 3.4 million, while FY 2025 net income was USD 32.69 million. The company said a Type A meeting has been scheduled between partner Pierre Fabre and the FDA regarding issues raised in a Complete Response Letter for tabelecleucel, and it expects existing liquidity plus USD 3 million of recent ATM proceeds to fund planned operations through year-end 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL7W0TZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2620499642","title":"Press Release: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2620499642","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620499642?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:05","pubTimestamp":1773691500,"startTime":"0","endTime":"0","summary":"Atara delivers significant operational efficiencies and extends cash runway through year-end 2026. A Type A meeting has been scheduled between Pierre Fabre Pharmaceuticals and the FDA. Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus  T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial results for the fourth quarter and full year 2025 and business updates.A Type A meeting with the U.S. Food and Drug Administration  has been scheduled for our partner Pierre Fabre Pharmaceuticals to discuss the issues raised by the FDA in the Complete Response Letter received in January 2026. We anticipate providing a regulatory update in the second quarter.million for the fourth quarter and fiscal year 2025, as compared to $24.5. and fiscal year 2025, respectively, as compared to a net loss of . million, or  per share, and  million, or  per sha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","TM","BK4588","ATRA","R","03160","BK4139","PRGS","BK4099","BK4097","BK4555","BK4585","BK4604","LU2065732104.USD","BK4022"],"gpt_icon":0},{"id":"2618539134","title":"Atara Schedules FDA Type A Meeting on EBVALLO Complete Response Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2618539134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618539134?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:11","pubTimestamp":1773317463,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics said it has scheduled a Type A meeting with the U.S. Food and Drug Administration to discuss the agency’s Complete Response Letter for the EBVALLO biologics license application for tabelecleucel, which the FDA issued on Jan. 9, 2026. The update signals the company is continuing regulatory discussions as it works to address issues raised by the FDA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atara Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL8Kn7xT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2618131791","title":"Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131791?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:05","pubTimestamp":1773317100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA6LFZ5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2616328607","title":"BRIEF-Atara Biotherapeutics Provides Regulatory Update On Tabelecleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2616328607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616328607?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:12","pubTimestamp":1772543547,"startTime":"0","endTime":"0","summary":"BRIEF-Atara Biotherapeutics Provides Regulatory Update On TabelecleucelMarch 3 (Reuters) - Atara Biotherapeutics Inc ATRA.O:ATARA BIOTHERAPEUTICS PROVIDES REGULATORY UPDATE ON TABELECLEUCELSource text: ID:nBwcf5zT8aFurther company coverage: ATRA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA7GKMFS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2616328331","title":"Atara Biotherapeutics reports Pierre Fabre request for FDA Type A meeting on tabelecleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2616328331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616328331?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:05","pubTimestamp":1772543116,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics said its partner Pierre Fabre Pharmaceuticals has submitted a request to the U.S. FDA for a Type A meeting regarding tabelecleucel . The companies submitted a briefing book addressing items raised in the FDA’s Complete Response Letter dated Jan. 9, 2026, and provided additional context and clarification that the ALLELE study was “adequate, well-controlled, and sufficient” to support the tab-cel Biologics License Application. The briefing book also includes updated longer-term efficacy data from ALLELE, additional supportive data from the tab-cel development program, and post-marketing data in Europe intended for inclusion in a potential resubmission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atara Biotherapeu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL3M9Cvc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2616832831","title":"Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2616832831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616832831?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:05","pubTimestamp":1772543100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA7GKMFS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2616334945","title":"Atara Biotherapeutics Inc  expected to post a loss of 37 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2616334945","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616334945?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:05","pubTimestamp":1772535907,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc  expected to post a loss of37cents a share - Earnings Preview Atara Biotherapeutics Inc ATRA.OQ ATRA.O is expected to  show a fall in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL8N3ZR13D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2616083333","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2616083333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616083333?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:00","pubTimestamp":1772449200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Crawford & Co                                  4Q       .23   4:15 PM. ·Credo Tech Hldg                                 3Q       .91   4:05 PM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIF","BEEP","ACR","CRD.B","ARCT","HCAT","BCYC","CVEO","BRCB","ALLO","ACHR","ANTA","EVGO","AMLX","FSTR","NPCE","GTLB","ASAN","AZO","STNE","ADT","CERS","BOX","EOLS","BBY","CORZ","CGEN","ASTH","ACEL","CRC","CYRX","CRD.A","AAON","CRCT","AMRC","BGS","AEO","GAIA","AFCG","DAVE","CXDO","ATRA","BLTE","DDD","ALG","ANF"],"gpt_icon":1},{"id":"2614832984","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832984","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614832984?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:00","pubTimestamp":1772190000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Arbor Realty Tr                                  4Q       .13   8:30 AM. ·Delek US Hldgs                                    4Q      (.19)  7:00 AM. ·NW Natural Hldg                                  4Q      1.36   6:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHR","ASAN","AMR","BCYC","BBY","AAON","ADT","BEEP","ALG","CRD.B","AMRC","CRC","ANIP","ACEL","AMWD","AMRX","BLTE","BRK.B","BOX","CGEN","GSAT","CLMT","CMPX","CRI","BRCB","CORZ","AMLX","ASTH","CVEO","BRK.A","STNE","BGS","NPCE","CXDO","ATRA","BTSG","ANTA","ALXO","LIF","ARCT","CRCT","CRD.A","ABR","AZO","CERS","ACRS"],"gpt_icon":1},{"id":"2613821867","title":"Atara Biotherapeutics amends HealthCare Royalty purchase, sale agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2613821867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613821867?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:15","pubTimestamp":1771852510,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics (ATRA) announced that the company entered into an amendment to the purchase and sale agreement dated as of December 20, 2022 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atara-biotherapeutics-amends-healthcare-royalty-purchase-sale-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atara-biotherapeutics-amends-healthcare-royalty-purchase-sale-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2613033784","title":"Atara Biotherapeutics Extends $9 Million HCRx Milestone Payment Due Date to 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2613033784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613033784?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:01","pubTimestamp":1771851687,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics, Inc. said it entered into an amendment to its December 20, 2022 Purchase and Sale Agreement with a fund managed by HealthCare Royalty . Under the amendment, HCRx agreed to extend the due date of a one-time $9.0 million cash payment tied to achievement of a milestone under Atara’s Amended and Restated Commercialization Agreement with Pierre Fabre Medicament from June 30, 2026 to January 1, 2028. In connection with the amendment, Atara issued a warrant to purchase up to 400,000 shares of common stock at an exercise price of $0.0001 per share, exercisable immediately with no expiration date, subject to a beneficial ownership limit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atara Biotherapeutics Inc. published t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLbh9Q7y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2613784272","title":"Atara Biotherapeutics Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2613784272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613784272?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA5ZBYDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2613784051","title":"Atara Biotherapeutics Inc - Hcrx Amends Due Date of $9 Mln Cash Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2613784051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613784051?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851608,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA5ZBYDS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2613074784","title":"Atara Biotherapeutics Inc - Payment Due Date Extended to January 1, 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2613074784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613074784?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851608,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA5ZBYDS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2604322531","title":"Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2604322531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604322531?lang=en_us&edition=fundamental","pubTime":"2026-01-20 00:30","pubTimestamp":1768840215,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc ($ATRA) announced an update on their ongoing clinical study. Study OverviewThis Phase 3 study, officially titled “Multice...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tabelecleucels-phase-3-ebv-ptld-trial-progress-signals-continued-potential-for-atara-biotherapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tabelecleucels-phase-3-ebv-ptld-trial-progress-signals-continued-potential-for-atara-biotherapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4139","BK4097","PRGS","ATRA"],"gpt_icon":0},{"id":"2603621292","title":"Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2603621292","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603621292?lang=en_us&edition=fundamental","pubTime":"2026-01-15 10:16","pubTimestamp":1768443414,"startTime":"0","endTime":"0","summary":"Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc               Panacea Innovation Ltd, a beneficial owner of Atara Biotherapeutics Inc., has reported a disposal of common...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL5qQkCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Panacea Innovation Ltd Sells Common Shares of Atara Biotherapeutics Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2603649942","title":"Atara's Outlook As Ebvallo Hits Second FDA CRL","url":"https://stock-news.laohu8.com/highlight/detail?id=2603649942","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603649942?lang=en_us&edition=fundamental","pubTime":"2026-01-15 02:28","pubTimestamp":1768415280,"startTime":"0","endTime":"0","summary":"The BLA is primarily supported by data from the Phase 3, single-arm, open-label ALLELE trial . In the ALLELE trial, Ebvallo met its prespecified primary efficacy endpoint and demonstrated a generally tolerable safety profile.It is noteworthy that Ebvallo had already received European Commission marketing authorization in the EU on 16 December 2022.In the U.S., Ebvallo previously received a CRL on January 15, 2025, which identified a single manufacturing compliance deficiency and did not raise concerns regarding safety, efficacy, or trial design.On January 9, 2026, Atara received a second FDA Complete Response Letter  for the Biologics License Application  for Ebvallo.Atara is currently at an extremely constrained net liquidity level. However, Atara has already monetized a portion of its Ebvallo EU royalty and certain milestone economics through the HCRx royalty-interest transaction. As Ebvallo has now been rejected by the FDA, the company may have very few remaining unencumbered assets","market":"sh","thumbnail":"/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["/next-assets/images/benzinga-post-card-placeholder.svg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/26/01/49916695/atara-outlook-as-ebvallo-hits-second-fda-crl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/Opinion/26/01/49916695/atara-outlook-as-ebvallo-hits-second-fda-crl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0757428866.USD","BK4139","LU0390134368.USD","LU0029874061.USD","LU1815336091.USD","ATRA","BK4585","CRL","BK4121","BK4588","BK4530","IE00BFMHRM44.USD","LU0128526141.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}